Advertisement
New results from the BLASST-1 trial show increases in downstaging and relapse-free survival
New neoadjuvant treatment regimen offers hope to patients facing a poor prognosis
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement